PCYT1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.073000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.807000E-01
Normal-vs-Stage2
4.719000E-01
Normal-vs-Stage3
9.943900E-02
Normal-vs-Stage4
9.943800E-01
Stage1-vs-Stage2
8.769800E-01
Stage1-vs-Stage3
2.664400E-01
Stage1-vs-Stage4
3.906400E-01
Stage2-vs-Stage3
2.680800E-01
Stage2-vs-Stage4
4.033800E-01
Stage3-vs-Stage4
1.327010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.844600E-01
Normal-vs-AfricanAmerican
8.953200E-01
Normal-vs-Asian
2.087600E-01
Caucasian-vs-AfricanAmerican
3.276000E-01
Caucasian-vs-Asian
6.460600E-01
AfricanAmerican-vs-Asian
2.310800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.457000E-01
Normal-vs-Female
3.534600E-01
Male-vs-Female
7.066600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.301160E-01
Normal-vs-Age(41-60Yrs)
7.910200E-01
Normal-vs-Age(61-80Yrs)
2.258000E-01
Normal-vs-Age(81-100Yrs)
2.253800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.369400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.156000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.076200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.709900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.314600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.020000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.082830E-01
Normal-vs-Daily Drinker
3.543500E-02
Normal-vs-Weekly Drinker
3.322400E-01
Normal-vs-Occasional Drinker
9.269600E-01
Normal-vs-Social Drinker
4.499800E-01
Non Drinker-vs-Daily Drinker
4.596200E-01
Non Drinker-vs-Weekly Drinker
3.957400E-01
Non Drinker-vs-Occasional Drinker
1.773170E-01
Non Drinker-vs-Social Drinker
1.238010E-01
Daily Drinker-vs-Weekly Drinker
1.495400E-01
Daily Drinker-vs-Occasional Drinker
1.008780E-01
Daily Drinker-vs-Social Drinker
3.019900E-02
Weekly Drinker-vs-Occasional Drinker
3.944200E-01
Weekly Drinker-vs-Social Drinker
6.009800E-01
Occasional Drinker-vs-Social Drinker
5.791400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.345000E-01
Normal-vs-Grade 2
1.103560E-01
Normal-vs-Grade 3
6.008300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.614430E-02
Grade 1-vs-Grade 3
1.187780E-02
Grade 1-vs-Grade 4
3.345000E-01
Grade 2-vs-Grade 3
8.988800E-01
Grade 2-vs-Grade 4
1.103560E-01
Grade 3-vs-Grade 4
6.008300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.847160E-01
Normal-vs-NonDiabetic
3.640400E-01
Diabetic-vs-NonDiabetic
6.372800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.714400E-01
Normal-vs-NoPancreatitis
3.474400E-01
Pancreatitis-vs-NoPancreatitis
6.355000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.591400E-01
Normal-vs-N1
4.876200E-01
N0-vs-N1
2.653400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.539000E-01
Normal-vs-TP53-NonMutant
2.775000E-01
TP53-Mutant-vs-TP53-NonMutant
1.040800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
